Your Article Summary
See Latest ArticlesPrevalence and Persistence of Cervical Human Papillomavirus Infection in HIV-Positive Women Initiating Highly Active Antiretroviral Therapy
Journal of Acquired Immune Deficiency Syndromes, 06/25/09
Fife KH et al. - Women initiating HAART had a high prevalence of cervical HPV DNA that declined over 96 weeks of HAART. The relationship of CD4 count and VL response to the decline of cervical HPV DNA was not strong.
Related Articles
Effectiveness of Increasing Emergency Department Patients' Self-perceived Risk for Being Human Immunodeficiency Virus (HIV) Infected Through Audio Computer Self-interview–based Feedback About Reported HIV Risk Behaviors
Academic Emergency Medicine, 11/11/09
Relevance Score: 95%
HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons
AIDS Patient Care and STDs, 10/06/09
Relevance Score: 95%
Mediators of HIV-related stigma and risk behavior in HIV infected young women
AIDS Care, 11/12/09
Relevance Score: 94%
Sperm May Play Leading Role In Spreading HIV
ScienceDaily, 10/27/09
Relevance Score: 94%
Female sex work and HIV risks in Croatia
AIDS Care, 10/29/09
Relevance Score: 93%
Today in HIV/Immunodeficiency...keeping you current
Receive free subspecialty "5-minute updates" via email
Optimal Management of HIV-Infected Women during Pregnancy and Delivery: An Audit of Compliance with Recommendations
Journal of Women's Health, 12/15/09
Pandemic influenza is a strong motivator for participation in vaccine clinical trials among HIV-positive Canadian adults
Canadian Journal of Infectious Diseases, 12/15/09
Replicative Capacity of Human Immunodeficiency Virus Type 1 Transmitted from Mother to Child Is Associated with Pediatric Disease Progression Rate
Journal of Virology, 12/15/09
Today in OB/TORCH Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
Optimal Management of HIV-Infected Women during Pregnancy and Delivery: An Audit of Compliance with Recommendations
Journal of Women's Health, 12/15/09
A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women
Contraception, 12/15/09
Cost-effectiveness of human papilloma virus vaccination in Iceland
Acta Obstetricia et Gynecologica Scandinavica, 12/15/09